SCHEDULE: ArrowMark Colorado Holdings Discloses 5.46% Stake in Tandem Diabetes
Beneficial Ownership Disclosure
ArrowMark Colorado Holdings, LLC has reported a 5.46% beneficial ownership stake in Tandem Diabetes Care Inc. common stock.
Summary
- ArrowMark Colorado Holdings, LLC has filed a Schedule 13G, indicating beneficial ownership of 3,691,198 shares of Tandem Diabetes Care Inc. common stock.
- This ownership represents 5.46% of the issuer's common stock class.
- The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- ArrowMark Colorado Holdings, LLC is classified as an Investment Adviser (IA).
Sentiment
Score: 5
Explanation: The filing is a standard disclosure of beneficial ownership by an investment adviser, indicating a passive stake. It contains no operational or financial updates to influence sentiment significantly, thus neutral.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by ArrowMark Colorado Holdings, LLC may be viewed as a positive signal of investor confidence in Tandem Diabetes Care Inc.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement |
| 11/13/2025 | Signature date of the filing |
Keywords
Tandem Diabetes Care Inc., ArrowMark Colorado Holdings LLC, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Medical Devices, Diabetes Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.